PSA (PSORIATIC ARTHRITIS)
Clinical trials for PSA (PSORIATIC ARTHRITIS) explained in plain language.
Never miss a new study
Get alerted when new PSA (PSORIATIC ARTHRITIS) trials appear
Sign up with your email to follow new studies for PSA (PSORIATIC ARTHRITIS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug candidate SPY002-072 aims to tame multiple inflammatory joint diseases
Disease control Recruiting nowThis study tests an experimental drug called SPY002-072 in 285 adults with moderately to severely active rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis. Participants receive either the drug or a placebo to see if it reduces joint pain, swelling, and inflamm…
Matched conditions: PSA (PSORIATIC ARTHRITIS)
Phase: PHASE2 • Sponsor: Spyre Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 04:36 UTC
-
New hope for psoriatic arthritis sufferers: experimental drug D-2570 enters phase 2 trial
Disease control Recruiting nowThis study tests an experimental drug called D-2570 in people with active psoriatic arthritis, a condition causing joint pain and swelling. About 222 adults aged 18 to 70 will receive either D-2570 or a placebo to see if the drug reduces joint tenderness and swelling. The main go…
Matched conditions: PSA (PSORIATIC ARTHRITIS)
Phase: PHASE2 • Sponsor: InventisBio Co., Ltd • Aim: Disease control
Last updated May 22, 2026 13:50 UTC